# Efficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill Patients

> **NCT05663905** · PHASE4 · COMPLETED · sponsor: **National University of Malaysia** · enrollment: 32 (actual)

## Conditions studied

- Severe Pneumonia
- Community-acquired Pneumonia
- Hospital-acquired Pneumonia
- Critical Illness

## Interventions

- **DRUG:** Ambroxol Hydrochloride
- **OTHER:** Standard Therapy

## Key facts

- **NCT ID:** NCT05663905
- **Lead sponsor:** National University of Malaysia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-07
- **Primary completion:** 2023-10-31
- **Final completion:** 2023-10-31
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2023-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05663905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05663905, "Efficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill Patients". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05663905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*